Medical Care
Global Transdermal Drug Delivery System Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
- Apr 07, 25
- ID: 165552
- Pages: 104
- Figures: 105
- Views: 43
The global Transdermal Drug Delivery System market size was US$ 19300 million in 2024 and is forecast to a readjusted size of US$ 36200 million by 2031 with a CAGR of 9.0% during the forecast period 2025-2031.
Transdermal Drug Delivery System is a medicated adhesive patch that is placed on the skin to deliver a specific dose of medication through the skin and into the bloodstream. Often, this promotes healing to an injured area of the body. An advantage of a transdermal drug delivery route over other types of medication delivery such as oral, topical, intravenous, intramuscular, etc. is that the patch provides a controlled release of the medication into the patient, usually through either a porous membrane covering a reservoir of medication or through body heat melting thin layers of medication embedded in the adhesive.
The transdermal drug delivery system (TDDS) market is driven by the increasing demand for non-invasive, convenient, and controlled drug administration methods. TDDS allows drugs to be delivered through the skin, bypassing the gastrointestinal tract and liver, which can reduce side effects and improve bioavailability. This method is especially beneficial for patients who have difficulty swallowing pills, those requiring continuous drug delivery, and individuals with chronic conditions like pain, hypertension, or diabetes. The market is also driven by advancements in technology, such as the development of better adhesive patches, microneedles, and nanocarriers, which enhance the efficiency and precision of drug delivery. These innovations are expanding the scope of TDDS applications, offering a wide range of therapeutic options.
Despite its growth, the transdermal drug delivery system market faces several challenges. One major limitation is the skin's barrier function, which restricts the absorption of larger or hydrophilic molecules, making it difficult to deliver certain drugs transdermally. Additionally, the high cost of developing and manufacturing TDDS products, as well as the need for specialized formulations, can deter smaller pharmaceutical companies from entering the market. Regulatory hurdles and concerns over the safety, efficacy, and long-term stability of transdermal formulations also present challenges. Furthermore, patient acceptance and the potential for skin irritation or allergic reactions to the adhesive components of TDDS patches may limit their widespread adoption.
The global Transdermal Drug Delivery System market is strategically segmented by company, region (country), by Type, and by Application. This report empowers stakeholders to capitalize on emerging opportunities, optimize product strategies, and outperform competitors through data-driven insights on revenue and forecasts across regions, by Type, and by Application for 2020-2031.
Market Segmentation
By Company:
Hisamitsu
Mylan
GSK
Novartis
Teve (Actavis)
Johnson & Johnson
Lohmann
Teikoku Seiyaku
Bayer
Lingrui
Sanofi
Qizheng
Endo
Huarun 999
Haw Par
Nichiban
Mentholatum
Laboratoires Genevrier
By Type: (Dominant Segment vs High-Margin Innovation)
Fentanyl
Nitroglycerin
Estradiol
Nicotine
Other
By Application: (Core Demand Driver vs Emerging Opportunity)
OTC
Rx
By Region
Macro-Regional Analysis: Market Size & Growth Forecasts
- North America
- Europe
- Asia-Pacific
- South America
- Middle East & Africa
Micro-Local Market Deep Dive: Strategic Insights
- Competitive Landscape: Player dominance vs. disruptors (e.g., Hisamitsu in Europe)
- Emerging Product Trends: Fentanyl adoption vs. Nitroglycerin premiumization
- Demand-Side Dynamics: OTC growth in China vs. Rx potential in North America
- Localized Consumer Needs: Regulatory hurdles in EU vs. price sensitivity in India
Focus Markets:
North America
Europe
China
Japan
Chapter Outline
Chapter 1: Report scope, executive summary, and market evolution scenarios (short/mid/long term).
Chapter 2: Quantitative analysis of Transdermal Drug Delivery System market size and growth potential at global, regional, and country levels.
Chapter 3: Competitive benchmarking of manufacturers (revenue, market share, M&A, R&D focus).
Chapter 4: Type-based segmentation analysis – Uncovering blue ocean markets (e.g., Nitroglycerin in China).
Chapter 5: Application-based segmentation analysis – High-growth downstream opportunities (e.g., Rx in India).
Chapter 6: Regional revenue breakdown by company, type, application and customer.
Chapter 7: Key manufacturer profiles – Financials, product portfolios, and strategic developments.
Chapter 8: Market dynamics – Drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 9: Actionable conclusions and strategic recommendations.
Why This Report?
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Transdermal Drug Delivery System value chain, addressing:
- Market entry risks/opportunities by region
- Product mix optimization based on local practices
- Competitor tactics in fragmented vs. consolidated markets
Transdermal Drug Delivery System is a medicated adhesive patch that is placed on the skin to deliver a specific dose of medication through the skin and into the bloodstream. Often, this promotes healing to an injured area of the body. An advantage of a transdermal drug delivery route over other types of medication delivery such as oral, topical, intravenous, intramuscular, etc. is that the patch provides a controlled release of the medication into the patient, usually through either a porous membrane covering a reservoir of medication or through body heat melting thin layers of medication embedded in the adhesive.
The transdermal drug delivery system (TDDS) market is driven by the increasing demand for non-invasive, convenient, and controlled drug administration methods. TDDS allows drugs to be delivered through the skin, bypassing the gastrointestinal tract and liver, which can reduce side effects and improve bioavailability. This method is especially beneficial for patients who have difficulty swallowing pills, those requiring continuous drug delivery, and individuals with chronic conditions like pain, hypertension, or diabetes. The market is also driven by advancements in technology, such as the development of better adhesive patches, microneedles, and nanocarriers, which enhance the efficiency and precision of drug delivery. These innovations are expanding the scope of TDDS applications, offering a wide range of therapeutic options.
Despite its growth, the transdermal drug delivery system market faces several challenges. One major limitation is the skin's barrier function, which restricts the absorption of larger or hydrophilic molecules, making it difficult to deliver certain drugs transdermally. Additionally, the high cost of developing and manufacturing TDDS products, as well as the need for specialized formulations, can deter smaller pharmaceutical companies from entering the market. Regulatory hurdles and concerns over the safety, efficacy, and long-term stability of transdermal formulations also present challenges. Furthermore, patient acceptance and the potential for skin irritation or allergic reactions to the adhesive components of TDDS patches may limit their widespread adoption.
The global Transdermal Drug Delivery System market is strategically segmented by company, region (country), by Type, and by Application. This report empowers stakeholders to capitalize on emerging opportunities, optimize product strategies, and outperform competitors through data-driven insights on revenue and forecasts across regions, by Type, and by Application for 2020-2031.
Market Segmentation
By Company:
Hisamitsu
Mylan
GSK
Novartis
Teve (Actavis)
Johnson & Johnson
Lohmann
Teikoku Seiyaku
Bayer
Lingrui
Sanofi
Qizheng
Endo
Huarun 999
Haw Par
Nichiban
Mentholatum
Laboratoires Genevrier
By Type: (Dominant Segment vs High-Margin Innovation)
Fentanyl
Nitroglycerin
Estradiol
Nicotine
Other
By Application: (Core Demand Driver vs Emerging Opportunity)
OTC
Rx
By Region
Macro-Regional Analysis: Market Size & Growth Forecasts
- North America
- Europe
- Asia-Pacific
- South America
- Middle East & Africa
Micro-Local Market Deep Dive: Strategic Insights
- Competitive Landscape: Player dominance vs. disruptors (e.g., Hisamitsu in Europe)
- Emerging Product Trends: Fentanyl adoption vs. Nitroglycerin premiumization
- Demand-Side Dynamics: OTC growth in China vs. Rx potential in North America
- Localized Consumer Needs: Regulatory hurdles in EU vs. price sensitivity in India
Focus Markets:
North America
Europe
China
Japan
Chapter Outline
Chapter 1: Report scope, executive summary, and market evolution scenarios (short/mid/long term).
Chapter 2: Quantitative analysis of Transdermal Drug Delivery System market size and growth potential at global, regional, and country levels.
Chapter 3: Competitive benchmarking of manufacturers (revenue, market share, M&A, R&D focus).
Chapter 4: Type-based segmentation analysis – Uncovering blue ocean markets (e.g., Nitroglycerin in China).
Chapter 5: Application-based segmentation analysis – High-growth downstream opportunities (e.g., Rx in India).
Chapter 6: Regional revenue breakdown by company, type, application and customer.
Chapter 7: Key manufacturer profiles – Financials, product portfolios, and strategic developments.
Chapter 8: Market dynamics – Drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 9: Actionable conclusions and strategic recommendations.
Why This Report?
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Transdermal Drug Delivery System value chain, addressing:
- Market entry risks/opportunities by region
- Product mix optimization based on local practices
- Competitor tactics in fragmented vs. consolidated markets
1 Report Overview
1.1 Study Scope
1.2 Market by Type
1.2.1 Global Market Size Growth by Type: 2020 VS 2024 VS 2031
1.2.2 Fentanyl
1.2.3 Nitroglycerin
1.2.4 Estradiol
1.2.5 Nicotine
1.2.6 Other
1.3 Market by Application
1.3.1 Global Market Share by Application: 2020 VS 2024 VS 2031
1.3.2 OTC
1.3.3 Rx
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Transdermal Drug Delivery System Market Perspective (2020-2031)
2.2 Global Market Size by Region: 2020 VS 2024 VS 2031
2.3 Global Transdermal Drug Delivery System Revenue Market Share by Region (2020-2025)
2.4 Global Transdermal Drug Delivery System Revenue Forecast by Region (2026-2031)
2.5 Major Region and Emerging Market Analysis
2.5.1 North America Transdermal Drug Delivery System Market Size and Prospective (2020-2031)
2.5.2 Europe Transdermal Drug Delivery System Market Size and Prospective (2020-2031)
2.5.3 China Transdermal Drug Delivery System Market Size and Prospective (2020-2031)
2.5.4 Japan Transdermal Drug Delivery System Market Size and Prospective (2020-2031)
3 Breakdown Data by Type
3.1 Global Transdermal Drug Delivery System Historic Market Size by Type (2020-2025)
3.2 Global Transdermal Drug Delivery System Forecasted Market Size by Type (2026-2031)
3.3 Different Types Transdermal Drug Delivery System Representative Players
4 Breakdown Data by Application
4.1 Global Transdermal Drug Delivery System Historic Market Size by Application (2020-2025)
4.2 Global Transdermal Drug Delivery System Forecasted Market Size by Application (2026-2031)
4.3 New Sources of Growth in Transdermal Drug Delivery System Application
5 Competition Landscape by Players
5.1 Global Top Players by Revenue
5.1.1 Global Top Transdermal Drug Delivery System Players by Revenue (2020-2025)
5.1.2 Global Transdermal Drug Delivery System Revenue Market Share by Players (2020-2025)
5.2 Global Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
5.3 Players Covered: Ranking by Transdermal Drug Delivery System Revenue
5.4 Global Transdermal Drug Delivery System Market Concentration Analysis
5.4.1 Global Transdermal Drug Delivery System Market Concentration Ratio (CR5 and HHI)
5.4.2 Global Top 10 and Top 5 Companies by Transdermal Drug Delivery System Revenue in 2024
5.5 Global Key Players of Transdermal Drug Delivery System Head office and Area Served
5.6 Global Key Players of Transdermal Drug Delivery System, Product and Application
5.7 Global Key Players of Transdermal Drug Delivery System, Date of Enter into This Industry
5.8 Mergers & Acquisitions, Expansion Plans
6 Region Analysis
6.1 North America Market: Players, Segments and Downstream
6.1.1 North America Transdermal Drug Delivery System Revenue by Company (2020-2025)
6.1.2 North America Market Size by Type
6.1.2.1 North America Transdermal Drug Delivery System Market Size by Type (2020-2025)
6.1.2.2 North America Transdermal Drug Delivery System Market Share by Type (2020-2025)
6.1.3 North America Market Size by Application
6.1.3.1 North America Transdermal Drug Delivery System Market Size by Application (2020-2025)
6.1.3.2 North America Transdermal Drug Delivery System Market Share by Application (2020-2025)
6.1.4 North America Market Trend and Opportunities
6.2 Europe Market: Players, Segments and Downstream
6.2.1 Europe Transdermal Drug Delivery System Revenue by Company (2020-2025)
6.2.2 Europe Market Size by Type
6.2.2.1 Europe Transdermal Drug Delivery System Market Size by Type (2020-2025)
6.2.2.2 Europe Transdermal Drug Delivery System Market Share by Type (2020-2025)
6.2.3 Europe Market Size by Application
6.2.3.1 Europe Transdermal Drug Delivery System Market Size by Application (2020-2025)
6.2.3.2 Europe Transdermal Drug Delivery System Market Share by Application (2020-2025)
6.2.4 Europe Market Trend and Opportunities
6.3 China Market: Players, Segments and Downstream
6.3.1 China Transdermal Drug Delivery System Revenue by Company (2020-2025)
6.3.2 China Market Size by Type
6.3.2.1 China Transdermal Drug Delivery System Market Size by Type (2020-2025)
6.3.2.2 China Transdermal Drug Delivery System Market Share by Type (2020-2025)
6.3.3 China Market Size by Application
6.3.3.1 China Transdermal Drug Delivery System Market Size by Application (2020-2025)
6.3.3.2 China Transdermal Drug Delivery System Market Share by Application (2020-2025)
6.3.4 China Market Trend and Opportunities
6.4 Japan Market: Players, Segments and Downstream
6.4.1 Japan Transdermal Drug Delivery System Revenue by Company (2020-2025)
6.4.2 Japan Market Size by Type
6.4.2.1 Japan Transdermal Drug Delivery System Market Size by Type (2020-2025)
6.4.2.2 Japan Transdermal Drug Delivery System Market Share by Type (2020-2025)
6.4.3 Japan Market Size by Application
6.4.3.1 Japan Transdermal Drug Delivery System Market Size by Application (2020-2025)
6.4.3.2 Japan Transdermal Drug Delivery System Market Share by Application (2020-2025)
6.4.4 Japan Market Trend and Opportunities
7 Key Players Profiles
7.1 Hisamitsu
7.1.1 Hisamitsu Company Details
7.1.2 Hisamitsu Business Overview
7.1.3 Hisamitsu Transdermal Drug Delivery System Introduction
7.1.4 Hisamitsu Revenue in Transdermal Drug Delivery System Business (2020-2025)
7.1.5 Hisamitsu Recent Development
7.2 Mylan
7.2.1 Mylan Company Details
7.2.2 Mylan Business Overview
7.2.3 Mylan Transdermal Drug Delivery System Introduction
7.2.4 Mylan Revenue in Transdermal Drug Delivery System Business (2020-2025)
7.2.5 Mylan Recent Development
7.3 GSK
7.3.1 GSK Company Details
7.3.2 GSK Business Overview
7.3.3 GSK Transdermal Drug Delivery System Introduction
7.3.4 GSK Revenue in Transdermal Drug Delivery System Business (2020-2025)
7.3.5 GSK Recent Development
7.4 Novartis
7.4.1 Novartis Company Details
7.4.2 Novartis Business Overview
7.4.3 Novartis Transdermal Drug Delivery System Introduction
7.4.4 Novartis Revenue in Transdermal Drug Delivery System Business (2020-2025)
7.4.5 Novartis Recent Development
7.5 Teve (Actavis)
7.5.1 Teve (Actavis) Company Details
7.5.2 Teve (Actavis) Business Overview
7.5.3 Teve (Actavis) Transdermal Drug Delivery System Introduction
7.5.4 Teve (Actavis) Revenue in Transdermal Drug Delivery System Business (2020-2025)
7.5.5 Teve (Actavis) Recent Development
7.6 Johnson & Johnson
7.6.1 Johnson & Johnson Company Details
7.6.2 Johnson & Johnson Business Overview
7.6.3 Johnson & Johnson Transdermal Drug Delivery System Introduction
7.6.4 Johnson & Johnson Revenue in Transdermal Drug Delivery System Business (2020-2025)
7.6.5 Johnson & Johnson Recent Development
7.7 Lohmann
7.7.1 Lohmann Company Details
7.7.2 Lohmann Business Overview
7.7.3 Lohmann Transdermal Drug Delivery System Introduction
7.7.4 Lohmann Revenue in Transdermal Drug Delivery System Business (2020-2025)
7.7.5 Lohmann Recent Development
7.8 Teikoku Seiyaku
7.8.1 Teikoku Seiyaku Company Details
7.8.2 Teikoku Seiyaku Business Overview
7.8.3 Teikoku Seiyaku Transdermal Drug Delivery System Introduction
7.8.4 Teikoku Seiyaku Revenue in Transdermal Drug Delivery System Business (2020-2025)
7.8.5 Teikoku Seiyaku Recent Development
7.9 Bayer
7.9.1 Bayer Company Details
7.9.2 Bayer Business Overview
7.9.3 Bayer Transdermal Drug Delivery System Introduction
7.9.4 Bayer Revenue in Transdermal Drug Delivery System Business (2020-2025)
7.9.5 Bayer Recent Development
7.10 Lingrui
7.10.1 Lingrui Company Details
7.10.2 Lingrui Business Overview
7.10.3 Lingrui Transdermal Drug Delivery System Introduction
7.10.4 Lingrui Revenue in Transdermal Drug Delivery System Business (2020-2025)
7.10.5 Lingrui Recent Development
7.11 Sanofi
7.11.1 Sanofi Company Details
7.11.2 Sanofi Business Overview
7.11.3 Sanofi Transdermal Drug Delivery System Introduction
7.11.4 Sanofi Revenue in Transdermal Drug Delivery System Business (2020-2025)
7.11.5 Sanofi Recent Development
7.12 Qizheng
7.12.1 Qizheng Company Details
7.12.2 Qizheng Business Overview
7.12.3 Qizheng Transdermal Drug Delivery System Introduction
7.12.4 Qizheng Revenue in Transdermal Drug Delivery System Business (2020-2025)
7.12.5 Qizheng Recent Development
7.13 Endo
7.13.1 Endo Company Details
7.13.2 Endo Business Overview
7.13.3 Endo Transdermal Drug Delivery System Introduction
7.13.4 Endo Revenue in Transdermal Drug Delivery System Business (2020-2025)
7.13.5 Endo Recent Development
7.14 Huarun 999
7.14.1 Huarun 999 Company Details
7.14.2 Huarun 999 Business Overview
7.14.3 Huarun 999 Transdermal Drug Delivery System Introduction
7.14.4 Huarun 999 Revenue in Transdermal Drug Delivery System Business (2020-2025)
7.14.5 Huarun 999 Recent Development
7.15 Haw Par
7.15.1 Haw Par Company Details
7.15.2 Haw Par Business Overview
7.15.3 Haw Par Transdermal Drug Delivery System Introduction
7.15.4 Haw Par Revenue in Transdermal Drug Delivery System Business (2020-2025)
7.15.5 Haw Par Recent Development
7.16 Nichiban
7.16.1 Nichiban Company Details
7.16.2 Nichiban Business Overview
7.16.3 Nichiban Transdermal Drug Delivery System Introduction
7.16.4 Nichiban Revenue in Transdermal Drug Delivery System Business (2020-2025)
7.16.5 Nichiban Recent Development
7.17 Mentholatum
7.17.1 Mentholatum Company Details
7.17.2 Mentholatum Business Overview
7.17.3 Mentholatum Transdermal Drug Delivery System Introduction
7.17.4 Mentholatum Revenue in Transdermal Drug Delivery System Business (2020-2025)
7.17.5 Mentholatum Recent Development
7.18 Laboratoires Genevrier
7.18.1 Laboratoires Genevrier Company Details
7.18.2 Laboratoires Genevrier Business Overview
7.18.3 Laboratoires Genevrier Transdermal Drug Delivery System Introduction
7.18.4 Laboratoires Genevrier Revenue in Transdermal Drug Delivery System Business (2020-2025)
7.18.5 Laboratoires Genevrier Recent Development
8 Transdermal Drug Delivery System Market Dynamics
8.1 Transdermal Drug Delivery System Industry Trends
8.2 Transdermal Drug Delivery System Market Drivers
8.3 Transdermal Drug Delivery System Market Challenges
8.4 Transdermal Drug Delivery System Market Restraints
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer
1.1 Study Scope
1.2 Market by Type
1.2.1 Global Market Size Growth by Type: 2020 VS 2024 VS 2031
1.2.2 Fentanyl
1.2.3 Nitroglycerin
1.2.4 Estradiol
1.2.5 Nicotine
1.2.6 Other
1.3 Market by Application
1.3.1 Global Market Share by Application: 2020 VS 2024 VS 2031
1.3.2 OTC
1.3.3 Rx
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Transdermal Drug Delivery System Market Perspective (2020-2031)
2.2 Global Market Size by Region: 2020 VS 2024 VS 2031
2.3 Global Transdermal Drug Delivery System Revenue Market Share by Region (2020-2025)
2.4 Global Transdermal Drug Delivery System Revenue Forecast by Region (2026-2031)
2.5 Major Region and Emerging Market Analysis
2.5.1 North America Transdermal Drug Delivery System Market Size and Prospective (2020-2031)
2.5.2 Europe Transdermal Drug Delivery System Market Size and Prospective (2020-2031)
2.5.3 China Transdermal Drug Delivery System Market Size and Prospective (2020-2031)
2.5.4 Japan Transdermal Drug Delivery System Market Size and Prospective (2020-2031)
3 Breakdown Data by Type
3.1 Global Transdermal Drug Delivery System Historic Market Size by Type (2020-2025)
3.2 Global Transdermal Drug Delivery System Forecasted Market Size by Type (2026-2031)
3.3 Different Types Transdermal Drug Delivery System Representative Players
4 Breakdown Data by Application
4.1 Global Transdermal Drug Delivery System Historic Market Size by Application (2020-2025)
4.2 Global Transdermal Drug Delivery System Forecasted Market Size by Application (2026-2031)
4.3 New Sources of Growth in Transdermal Drug Delivery System Application
5 Competition Landscape by Players
5.1 Global Top Players by Revenue
5.1.1 Global Top Transdermal Drug Delivery System Players by Revenue (2020-2025)
5.1.2 Global Transdermal Drug Delivery System Revenue Market Share by Players (2020-2025)
5.2 Global Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
5.3 Players Covered: Ranking by Transdermal Drug Delivery System Revenue
5.4 Global Transdermal Drug Delivery System Market Concentration Analysis
5.4.1 Global Transdermal Drug Delivery System Market Concentration Ratio (CR5 and HHI)
5.4.2 Global Top 10 and Top 5 Companies by Transdermal Drug Delivery System Revenue in 2024
5.5 Global Key Players of Transdermal Drug Delivery System Head office and Area Served
5.6 Global Key Players of Transdermal Drug Delivery System, Product and Application
5.7 Global Key Players of Transdermal Drug Delivery System, Date of Enter into This Industry
5.8 Mergers & Acquisitions, Expansion Plans
6 Region Analysis
6.1 North America Market: Players, Segments and Downstream
6.1.1 North America Transdermal Drug Delivery System Revenue by Company (2020-2025)
6.1.2 North America Market Size by Type
6.1.2.1 North America Transdermal Drug Delivery System Market Size by Type (2020-2025)
6.1.2.2 North America Transdermal Drug Delivery System Market Share by Type (2020-2025)
6.1.3 North America Market Size by Application
6.1.3.1 North America Transdermal Drug Delivery System Market Size by Application (2020-2025)
6.1.3.2 North America Transdermal Drug Delivery System Market Share by Application (2020-2025)
6.1.4 North America Market Trend and Opportunities
6.2 Europe Market: Players, Segments and Downstream
6.2.1 Europe Transdermal Drug Delivery System Revenue by Company (2020-2025)
6.2.2 Europe Market Size by Type
6.2.2.1 Europe Transdermal Drug Delivery System Market Size by Type (2020-2025)
6.2.2.2 Europe Transdermal Drug Delivery System Market Share by Type (2020-2025)
6.2.3 Europe Market Size by Application
6.2.3.1 Europe Transdermal Drug Delivery System Market Size by Application (2020-2025)
6.2.3.2 Europe Transdermal Drug Delivery System Market Share by Application (2020-2025)
6.2.4 Europe Market Trend and Opportunities
6.3 China Market: Players, Segments and Downstream
6.3.1 China Transdermal Drug Delivery System Revenue by Company (2020-2025)
6.3.2 China Market Size by Type
6.3.2.1 China Transdermal Drug Delivery System Market Size by Type (2020-2025)
6.3.2.2 China Transdermal Drug Delivery System Market Share by Type (2020-2025)
6.3.3 China Market Size by Application
6.3.3.1 China Transdermal Drug Delivery System Market Size by Application (2020-2025)
6.3.3.2 China Transdermal Drug Delivery System Market Share by Application (2020-2025)
6.3.4 China Market Trend and Opportunities
6.4 Japan Market: Players, Segments and Downstream
6.4.1 Japan Transdermal Drug Delivery System Revenue by Company (2020-2025)
6.4.2 Japan Market Size by Type
6.4.2.1 Japan Transdermal Drug Delivery System Market Size by Type (2020-2025)
6.4.2.2 Japan Transdermal Drug Delivery System Market Share by Type (2020-2025)
6.4.3 Japan Market Size by Application
6.4.3.1 Japan Transdermal Drug Delivery System Market Size by Application (2020-2025)
6.4.3.2 Japan Transdermal Drug Delivery System Market Share by Application (2020-2025)
6.4.4 Japan Market Trend and Opportunities
7 Key Players Profiles
7.1 Hisamitsu
7.1.1 Hisamitsu Company Details
7.1.2 Hisamitsu Business Overview
7.1.3 Hisamitsu Transdermal Drug Delivery System Introduction
7.1.4 Hisamitsu Revenue in Transdermal Drug Delivery System Business (2020-2025)
7.1.5 Hisamitsu Recent Development
7.2 Mylan
7.2.1 Mylan Company Details
7.2.2 Mylan Business Overview
7.2.3 Mylan Transdermal Drug Delivery System Introduction
7.2.4 Mylan Revenue in Transdermal Drug Delivery System Business (2020-2025)
7.2.5 Mylan Recent Development
7.3 GSK
7.3.1 GSK Company Details
7.3.2 GSK Business Overview
7.3.3 GSK Transdermal Drug Delivery System Introduction
7.3.4 GSK Revenue in Transdermal Drug Delivery System Business (2020-2025)
7.3.5 GSK Recent Development
7.4 Novartis
7.4.1 Novartis Company Details
7.4.2 Novartis Business Overview
7.4.3 Novartis Transdermal Drug Delivery System Introduction
7.4.4 Novartis Revenue in Transdermal Drug Delivery System Business (2020-2025)
7.4.5 Novartis Recent Development
7.5 Teve (Actavis)
7.5.1 Teve (Actavis) Company Details
7.5.2 Teve (Actavis) Business Overview
7.5.3 Teve (Actavis) Transdermal Drug Delivery System Introduction
7.5.4 Teve (Actavis) Revenue in Transdermal Drug Delivery System Business (2020-2025)
7.5.5 Teve (Actavis) Recent Development
7.6 Johnson & Johnson
7.6.1 Johnson & Johnson Company Details
7.6.2 Johnson & Johnson Business Overview
7.6.3 Johnson & Johnson Transdermal Drug Delivery System Introduction
7.6.4 Johnson & Johnson Revenue in Transdermal Drug Delivery System Business (2020-2025)
7.6.5 Johnson & Johnson Recent Development
7.7 Lohmann
7.7.1 Lohmann Company Details
7.7.2 Lohmann Business Overview
7.7.3 Lohmann Transdermal Drug Delivery System Introduction
7.7.4 Lohmann Revenue in Transdermal Drug Delivery System Business (2020-2025)
7.7.5 Lohmann Recent Development
7.8 Teikoku Seiyaku
7.8.1 Teikoku Seiyaku Company Details
7.8.2 Teikoku Seiyaku Business Overview
7.8.3 Teikoku Seiyaku Transdermal Drug Delivery System Introduction
7.8.4 Teikoku Seiyaku Revenue in Transdermal Drug Delivery System Business (2020-2025)
7.8.5 Teikoku Seiyaku Recent Development
7.9 Bayer
7.9.1 Bayer Company Details
7.9.2 Bayer Business Overview
7.9.3 Bayer Transdermal Drug Delivery System Introduction
7.9.4 Bayer Revenue in Transdermal Drug Delivery System Business (2020-2025)
7.9.5 Bayer Recent Development
7.10 Lingrui
7.10.1 Lingrui Company Details
7.10.2 Lingrui Business Overview
7.10.3 Lingrui Transdermal Drug Delivery System Introduction
7.10.4 Lingrui Revenue in Transdermal Drug Delivery System Business (2020-2025)
7.10.5 Lingrui Recent Development
7.11 Sanofi
7.11.1 Sanofi Company Details
7.11.2 Sanofi Business Overview
7.11.3 Sanofi Transdermal Drug Delivery System Introduction
7.11.4 Sanofi Revenue in Transdermal Drug Delivery System Business (2020-2025)
7.11.5 Sanofi Recent Development
7.12 Qizheng
7.12.1 Qizheng Company Details
7.12.2 Qizheng Business Overview
7.12.3 Qizheng Transdermal Drug Delivery System Introduction
7.12.4 Qizheng Revenue in Transdermal Drug Delivery System Business (2020-2025)
7.12.5 Qizheng Recent Development
7.13 Endo
7.13.1 Endo Company Details
7.13.2 Endo Business Overview
7.13.3 Endo Transdermal Drug Delivery System Introduction
7.13.4 Endo Revenue in Transdermal Drug Delivery System Business (2020-2025)
7.13.5 Endo Recent Development
7.14 Huarun 999
7.14.1 Huarun 999 Company Details
7.14.2 Huarun 999 Business Overview
7.14.3 Huarun 999 Transdermal Drug Delivery System Introduction
7.14.4 Huarun 999 Revenue in Transdermal Drug Delivery System Business (2020-2025)
7.14.5 Huarun 999 Recent Development
7.15 Haw Par
7.15.1 Haw Par Company Details
7.15.2 Haw Par Business Overview
7.15.3 Haw Par Transdermal Drug Delivery System Introduction
7.15.4 Haw Par Revenue in Transdermal Drug Delivery System Business (2020-2025)
7.15.5 Haw Par Recent Development
7.16 Nichiban
7.16.1 Nichiban Company Details
7.16.2 Nichiban Business Overview
7.16.3 Nichiban Transdermal Drug Delivery System Introduction
7.16.4 Nichiban Revenue in Transdermal Drug Delivery System Business (2020-2025)
7.16.5 Nichiban Recent Development
7.17 Mentholatum
7.17.1 Mentholatum Company Details
7.17.2 Mentholatum Business Overview
7.17.3 Mentholatum Transdermal Drug Delivery System Introduction
7.17.4 Mentholatum Revenue in Transdermal Drug Delivery System Business (2020-2025)
7.17.5 Mentholatum Recent Development
7.18 Laboratoires Genevrier
7.18.1 Laboratoires Genevrier Company Details
7.18.2 Laboratoires Genevrier Business Overview
7.18.3 Laboratoires Genevrier Transdermal Drug Delivery System Introduction
7.18.4 Laboratoires Genevrier Revenue in Transdermal Drug Delivery System Business (2020-2025)
7.18.5 Laboratoires Genevrier Recent Development
8 Transdermal Drug Delivery System Market Dynamics
8.1 Transdermal Drug Delivery System Industry Trends
8.2 Transdermal Drug Delivery System Market Drivers
8.3 Transdermal Drug Delivery System Market Challenges
8.4 Transdermal Drug Delivery System Market Restraints
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer
List of Tables
Table 1. Global Transdermal Drug Delivery System Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Global Transdermal Drug Delivery System Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 3. Global Market Transdermal Drug Delivery System Market Size (US$ Million) by Region:2020 VS 2024 VS 2031
Table 4. Global Transdermal Drug Delivery System Revenue (US$ Million) Market Share by Region (2020-2025)
Table 5. Global Transdermal Drug Delivery System Revenue Share by Region (2020-2025)
Table 6. Global Transdermal Drug Delivery System Revenue (US$ Million) Forecast by Region (2026-2031)
Table 7. Global Transdermal Drug Delivery System Revenue Share Forecast by Region (2026-2031)
Table 8. Global Transdermal Drug Delivery System Market Size by Type (2020-2025) & (US$ Million)
Table 9. Global Transdermal Drug Delivery System Revenue Market Share by Type (2020-2025)
Table 10. Global Transdermal Drug Delivery System Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 11. Global Transdermal Drug Delivery System Revenue Market Share by Type (2026-2031)
Table 12. Representative Players of Each Type
Table 13. Global Transdermal Drug Delivery System Market Size by Application (2020-2025) & (US$ Million)
Table 14. Global Transdermal Drug Delivery System Revenue Market Share by Application (2020-2025)
Table 15. Global Transdermal Drug Delivery System Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 16. Global Transdermal Drug Delivery System Revenue Market Share by Application (2026-2031)
Table 17. New Sources of Growth in Transdermal Drug Delivery System Application
Table 18. Global Transdermal Drug Delivery System Revenue by Players (2020-2025) & (US$ Million)
Table 19. Global Transdermal Drug Delivery System Market Share by Players (2020-2025)
Table 20. Global Top Transdermal Drug Delivery System Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Transdermal Drug Delivery System as of 2024)
Table 21. Ranking of Global Top Transdermal Drug Delivery System Companies by Revenue (US$ Million) in 2024
Table 22. Global 5 Largest Players Market Share by Transdermal Drug Delivery System Revenue (CR5 and HHI) & (2020-2025)
Table 23. Global Key Players of Transdermal Drug Delivery System, Headquarters and Area Served
Table 24. Global Key Players of Transdermal Drug Delivery System, Product and Application
Table 25. Global Key Players of Transdermal Drug Delivery System, Date of Enter into This Industry
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. North America Transdermal Drug Delivery System Revenue by Company (2020-2025) & (US$ Million)
Table 28. North America Transdermal Drug Delivery System Revenue Market Share by Company (2020-2025)
Table 29. North America Transdermal Drug Delivery System Market Size by Type (2020-2025) & (US$ Million)
Table 30. North America Transdermal Drug Delivery System Market Size by Application (2020-2025) & (US$ Million)
Table 31. Europe Transdermal Drug Delivery System Revenue by Company (2020-2025) & (US$ Million)
Table 32. Europe Transdermal Drug Delivery System Revenue Market Share by Company (2020-2025)
Table 33. Europe Transdermal Drug Delivery System Market Size by Type (2020-2025) & (US$ Million)
Table 34. Europe Transdermal Drug Delivery System Market Size by Application (2020-2025) & (US$ Million)
Table 35. China Transdermal Drug Delivery System Revenue by Company (2020-2025) & (US$ Million)
Table 36. China Transdermal Drug Delivery System Revenue Market Share by Company (2020-2025)
Table 37. China Transdermal Drug Delivery System Market Size by Type (2020-2025) & (US$ Million)
Table 38. China Transdermal Drug Delivery System Market Size by Application (2020-2025) & (US$ Million)
Table 39. Japan Transdermal Drug Delivery System Revenue by Company (2020-2025) & (US$ Million)
Table 40. Japan Transdermal Drug Delivery System Revenue Market Share by Company (2020-2025)
Table 41. Japan Transdermal Drug Delivery System Market Size by Type (2020-2025) & (US$ Million)
Table 42. Japan Transdermal Drug Delivery System Market Size by Application (2020-2025) & (US$ Million)
Table 43. Hisamitsu Company Details
Table 44. Hisamitsu Business Overview
Table 45. Hisamitsu Transdermal Drug Delivery System Product
Table 46. Hisamitsu Revenue in Transdermal Drug Delivery System Business (2020-2025) & (US$ Million)
Table 47. Hisamitsu Recent Development
Table 48. Mylan Company Details
Table 49. Mylan Business Overview
Table 50. Mylan Transdermal Drug Delivery System Product
Table 51. Mylan Revenue in Transdermal Drug Delivery System Business (2020-2025) & (US$ Million)
Table 52. Mylan Recent Development
Table 53. GSK Company Details
Table 54. GSK Business Overview
Table 55. GSK Transdermal Drug Delivery System Product
Table 56. GSK Revenue in Transdermal Drug Delivery System Business (2020-2025) & (US$ Million)
Table 57. GSK Recent Development
Table 58. Novartis Company Details
Table 59. Novartis Business Overview
Table 60. Novartis Transdermal Drug Delivery System Product
Table 61. Novartis Revenue in Transdermal Drug Delivery System Business (2020-2025) & (US$ Million)
Table 62. Novartis Recent Development
Table 63. Teve (Actavis) Company Details
Table 64. Teve (Actavis) Business Overview
Table 65. Teve (Actavis) Transdermal Drug Delivery System Product
Table 66. Teve (Actavis) Revenue in Transdermal Drug Delivery System Business (2020-2025) & (US$ Million)
Table 67. Teve (Actavis) Recent Development
Table 68. Johnson & Johnson Company Details
Table 69. Johnson & Johnson Business Overview
Table 70. Johnson & Johnson Transdermal Drug Delivery System Product
Table 71. Johnson & Johnson Revenue in Transdermal Drug Delivery System Business (2020-2025) & (US$ Million)
Table 72. Johnson & Johnson Recent Development
Table 73. Lohmann Company Details
Table 74. Lohmann Business Overview
Table 75. Lohmann Transdermal Drug Delivery System Product
Table 76. Lohmann Revenue in Transdermal Drug Delivery System Business (2020-2025) & (US$ Million)
Table 77. Lohmann Recent Development
Table 78. Teikoku Seiyaku Company Details
Table 79. Teikoku Seiyaku Business Overview
Table 80. Teikoku Seiyaku Transdermal Drug Delivery System Product
Table 81. Teikoku Seiyaku Revenue in Transdermal Drug Delivery System Business (2020-2025) & (US$ Million)
Table 82. Teikoku Seiyaku Recent Development
Table 83. Bayer Company Details
Table 84. Bayer Business Overview
Table 85. Bayer Transdermal Drug Delivery System Product
Table 86. Bayer Revenue in Transdermal Drug Delivery System Business (2020-2025) & (US$ Million)
Table 87. Bayer Recent Development
Table 88. Lingrui Company Details
Table 89. Lingrui Business Overview
Table 90. Lingrui Transdermal Drug Delivery System Product
Table 91. Lingrui Revenue in Transdermal Drug Delivery System Business (2020-2025) & (US$ Million)
Table 92. Lingrui Recent Development
Table 93. Sanofi Company Details
Table 94. Sanofi Business Overview
Table 95. Sanofi Transdermal Drug Delivery System Product
Table 96. Sanofi Revenue in Transdermal Drug Delivery System Business (2020-2025) & (US$ Million)
Table 97. Sanofi Recent Development
Table 98. Qizheng Company Details
Table 99. Qizheng Business Overview
Table 100. Qizheng Transdermal Drug Delivery System Product
Table 101. Qizheng Revenue in Transdermal Drug Delivery System Business (2020-2025) & (US$ Million)
Table 102. Qizheng Recent Development
Table 103. Endo Company Details
Table 104. Endo Business Overview
Table 105. Endo Transdermal Drug Delivery System Product
Table 106. Endo Revenue in Transdermal Drug Delivery System Business (2020-2025) & (US$ Million)
Table 107. Endo Recent Development
Table 108. Huarun 999 Company Details
Table 109. Huarun 999 Business Overview
Table 110. Huarun 999 Transdermal Drug Delivery System Product
Table 111. Huarun 999 Revenue in Transdermal Drug Delivery System Business (2020-2025) & (US$ Million)
Table 112. Huarun 999 Recent Development
Table 113. Haw Par Company Details
Table 114. Haw Par Business Overview
Table 115. Haw Par Transdermal Drug Delivery System Product
Table 116. Haw Par Revenue in Transdermal Drug Delivery System Business (2020-2025) & (US$ Million)
Table 117. Haw Par Recent Development
Table 118. Nichiban Company Details
Table 119. Nichiban Business Overview
Table 120. Nichiban Transdermal Drug Delivery System Product
Table 121. Nichiban Revenue in Transdermal Drug Delivery System Business (2020-2025) & (US$ Million)
Table 122. Nichiban Recent Development
Table 123. Mentholatum Company Details
Table 124. Mentholatum Business Overview
Table 125. Mentholatum Transdermal Drug Delivery System Product
Table 126. Mentholatum Revenue in Transdermal Drug Delivery System Business (2020-2025) & (US$ Million)
Table 127. Mentholatum Recent Development
Table 128. Laboratoires Genevrier Company Details
Table 129. Laboratoires Genevrier Business Overview
Table 130. Laboratoires Genevrier Transdermal Drug Delivery System Product
Table 131. Laboratoires Genevrier Revenue in Transdermal Drug Delivery System Business (2020-2025) & (US$ Million)
Table 132. Laboratoires Genevrier Recent Development
Table 133. Transdermal Drug Delivery System Market Trends
Table 134. Transdermal Drug Delivery System Market Drivers
Table 135. Transdermal Drug Delivery System Market Challenges
Table 136. Transdermal Drug Delivery System Market Restraints
Table 137. Research Programs/Design for This Report
Table 138. Key Data Information from Secondary Sources
Table 139. Key Data Information from Primary Sources
List of Figures
Figure 1. Transdermal Drug Delivery System Product Picture
Figure 2. Global Transdermal Drug Delivery System Market Share by Type: 2024 VS 2031
Figure 3. Fentanyl Features
Figure 4. Nitroglycerin Features
Figure 5. Estradiol Features
Figure 6. Nicotine Features
Figure 7. Other Features
Figure 8. Global Transdermal Drug Delivery System Market Share by Application: 2024 VS 2031
Figure 9. OTC
Figure 10. Rx
Figure 11. Transdermal Drug Delivery System Report Years Considered
Figure 12. Global Transdermal Drug Delivery System Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 13. Global Transdermal Drug Delivery System Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 14. Global Transdermal Drug Delivery System Revenue Market Share by Region: 2020 VS 2024
Figure 15. North America Transdermal Drug Delivery System Revenue (US$ Million) Growth Rate (2020-2031)
Figure 16. Europe Transdermal Drug Delivery System Revenue (US$ Million) Growth Rate (2020-2031)
Figure 17. China Transdermal Drug Delivery System Revenue (US$ Million) Growth Rate (2020-2031)
Figure 18. Japan Transdermal Drug Delivery System Revenue (US$ Million) Growth Rate (2020-2031)
Figure 19. Global Transdermal Drug Delivery System Market Share by Players in 2024
Figure 20. Global Top Transdermal Drug Delivery System Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Transdermal Drug Delivery System as of 2024)
Figure 21. The Top 10 and 5 Players Market Share by Transdermal Drug Delivery System Revenue in 2024
Figure 22. North America Transdermal Drug Delivery System Market Share by Type (2020-2025)
Figure 23. North America Transdermal Drug Delivery System Market Share by Application (2020-2025)
Figure 24. Europe Transdermal Drug Delivery System Market Share by Type (2020-2025)
Figure 25. Europe Transdermal Drug Delivery System Market Share by Application (2020-2025)
Figure 26. China Transdermal Drug Delivery System Market Share by Type (2020-2025)
Figure 27. China Transdermal Drug Delivery System Market Share by Application (2020-2025)
Figure 28. Japan Transdermal Drug Delivery System Market Share by Type (2020-2025)
Figure 29. Japan Transdermal Drug Delivery System Market Share by Application (2020-2025)
Figure 30. Hisamitsu Revenue Growth Rate in Transdermal Drug Delivery System Business (2020-2025)
Figure 31. Mylan Revenue Growth Rate in Transdermal Drug Delivery System Business (2020-2025)
Figure 32. GSK Revenue Growth Rate in Transdermal Drug Delivery System Business (2020-2025)
Figure 33. Novartis Revenue Growth Rate in Transdermal Drug Delivery System Business (2020-2025)
Figure 34. Teve (Actavis) Revenue Growth Rate in Transdermal Drug Delivery System Business (2020-2025)
Figure 35. Johnson & Johnson Revenue Growth Rate in Transdermal Drug Delivery System Business (2020-2025)
Figure 36. Lohmann Revenue Growth Rate in Transdermal Drug Delivery System Business (2020-2025)
Figure 37. Teikoku Seiyaku Revenue Growth Rate in Transdermal Drug Delivery System Business (2020-2025)
Figure 38. Bayer Revenue Growth Rate in Transdermal Drug Delivery System Business (2020-2025)
Figure 39. Lingrui Revenue Growth Rate in Transdermal Drug Delivery System Business (2020-2025)
Figure 40. Sanofi Revenue Growth Rate in Transdermal Drug Delivery System Business (2020-2025)
Figure 41. Qizheng Revenue Growth Rate in Transdermal Drug Delivery System Business (2020-2025)
Figure 42. Endo Revenue Growth Rate in Transdermal Drug Delivery System Business (2020-2025)
Figure 43. Huarun 999 Revenue Growth Rate in Transdermal Drug Delivery System Business (2020-2025)
Figure 44. Haw Par Revenue Growth Rate in Transdermal Drug Delivery System Business (2020-2025)
Figure 45. Nichiban Revenue Growth Rate in Transdermal Drug Delivery System Business (2020-2025)
Figure 46. Mentholatum Revenue Growth Rate in Transdermal Drug Delivery System Business (2020-2025)
Figure 47. Laboratoires Genevrier Revenue Growth Rate in Transdermal Drug Delivery System Business (2020-2025)
Figure 48. Bottom-up and Top-down Approaches for This Report
Figure 49. Data Triangulation
Figure 50. Key Executives Interviewed
Table 1. Global Transdermal Drug Delivery System Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Global Transdermal Drug Delivery System Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 3. Global Market Transdermal Drug Delivery System Market Size (US$ Million) by Region:2020 VS 2024 VS 2031
Table 4. Global Transdermal Drug Delivery System Revenue (US$ Million) Market Share by Region (2020-2025)
Table 5. Global Transdermal Drug Delivery System Revenue Share by Region (2020-2025)
Table 6. Global Transdermal Drug Delivery System Revenue (US$ Million) Forecast by Region (2026-2031)
Table 7. Global Transdermal Drug Delivery System Revenue Share Forecast by Region (2026-2031)
Table 8. Global Transdermal Drug Delivery System Market Size by Type (2020-2025) & (US$ Million)
Table 9. Global Transdermal Drug Delivery System Revenue Market Share by Type (2020-2025)
Table 10. Global Transdermal Drug Delivery System Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 11. Global Transdermal Drug Delivery System Revenue Market Share by Type (2026-2031)
Table 12. Representative Players of Each Type
Table 13. Global Transdermal Drug Delivery System Market Size by Application (2020-2025) & (US$ Million)
Table 14. Global Transdermal Drug Delivery System Revenue Market Share by Application (2020-2025)
Table 15. Global Transdermal Drug Delivery System Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 16. Global Transdermal Drug Delivery System Revenue Market Share by Application (2026-2031)
Table 17. New Sources of Growth in Transdermal Drug Delivery System Application
Table 18. Global Transdermal Drug Delivery System Revenue by Players (2020-2025) & (US$ Million)
Table 19. Global Transdermal Drug Delivery System Market Share by Players (2020-2025)
Table 20. Global Top Transdermal Drug Delivery System Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Transdermal Drug Delivery System as of 2024)
Table 21. Ranking of Global Top Transdermal Drug Delivery System Companies by Revenue (US$ Million) in 2024
Table 22. Global 5 Largest Players Market Share by Transdermal Drug Delivery System Revenue (CR5 and HHI) & (2020-2025)
Table 23. Global Key Players of Transdermal Drug Delivery System, Headquarters and Area Served
Table 24. Global Key Players of Transdermal Drug Delivery System, Product and Application
Table 25. Global Key Players of Transdermal Drug Delivery System, Date of Enter into This Industry
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. North America Transdermal Drug Delivery System Revenue by Company (2020-2025) & (US$ Million)
Table 28. North America Transdermal Drug Delivery System Revenue Market Share by Company (2020-2025)
Table 29. North America Transdermal Drug Delivery System Market Size by Type (2020-2025) & (US$ Million)
Table 30. North America Transdermal Drug Delivery System Market Size by Application (2020-2025) & (US$ Million)
Table 31. Europe Transdermal Drug Delivery System Revenue by Company (2020-2025) & (US$ Million)
Table 32. Europe Transdermal Drug Delivery System Revenue Market Share by Company (2020-2025)
Table 33. Europe Transdermal Drug Delivery System Market Size by Type (2020-2025) & (US$ Million)
Table 34. Europe Transdermal Drug Delivery System Market Size by Application (2020-2025) & (US$ Million)
Table 35. China Transdermal Drug Delivery System Revenue by Company (2020-2025) & (US$ Million)
Table 36. China Transdermal Drug Delivery System Revenue Market Share by Company (2020-2025)
Table 37. China Transdermal Drug Delivery System Market Size by Type (2020-2025) & (US$ Million)
Table 38. China Transdermal Drug Delivery System Market Size by Application (2020-2025) & (US$ Million)
Table 39. Japan Transdermal Drug Delivery System Revenue by Company (2020-2025) & (US$ Million)
Table 40. Japan Transdermal Drug Delivery System Revenue Market Share by Company (2020-2025)
Table 41. Japan Transdermal Drug Delivery System Market Size by Type (2020-2025) & (US$ Million)
Table 42. Japan Transdermal Drug Delivery System Market Size by Application (2020-2025) & (US$ Million)
Table 43. Hisamitsu Company Details
Table 44. Hisamitsu Business Overview
Table 45. Hisamitsu Transdermal Drug Delivery System Product
Table 46. Hisamitsu Revenue in Transdermal Drug Delivery System Business (2020-2025) & (US$ Million)
Table 47. Hisamitsu Recent Development
Table 48. Mylan Company Details
Table 49. Mylan Business Overview
Table 50. Mylan Transdermal Drug Delivery System Product
Table 51. Mylan Revenue in Transdermal Drug Delivery System Business (2020-2025) & (US$ Million)
Table 52. Mylan Recent Development
Table 53. GSK Company Details
Table 54. GSK Business Overview
Table 55. GSK Transdermal Drug Delivery System Product
Table 56. GSK Revenue in Transdermal Drug Delivery System Business (2020-2025) & (US$ Million)
Table 57. GSK Recent Development
Table 58. Novartis Company Details
Table 59. Novartis Business Overview
Table 60. Novartis Transdermal Drug Delivery System Product
Table 61. Novartis Revenue in Transdermal Drug Delivery System Business (2020-2025) & (US$ Million)
Table 62. Novartis Recent Development
Table 63. Teve (Actavis) Company Details
Table 64. Teve (Actavis) Business Overview
Table 65. Teve (Actavis) Transdermal Drug Delivery System Product
Table 66. Teve (Actavis) Revenue in Transdermal Drug Delivery System Business (2020-2025) & (US$ Million)
Table 67. Teve (Actavis) Recent Development
Table 68. Johnson & Johnson Company Details
Table 69. Johnson & Johnson Business Overview
Table 70. Johnson & Johnson Transdermal Drug Delivery System Product
Table 71. Johnson & Johnson Revenue in Transdermal Drug Delivery System Business (2020-2025) & (US$ Million)
Table 72. Johnson & Johnson Recent Development
Table 73. Lohmann Company Details
Table 74. Lohmann Business Overview
Table 75. Lohmann Transdermal Drug Delivery System Product
Table 76. Lohmann Revenue in Transdermal Drug Delivery System Business (2020-2025) & (US$ Million)
Table 77. Lohmann Recent Development
Table 78. Teikoku Seiyaku Company Details
Table 79. Teikoku Seiyaku Business Overview
Table 80. Teikoku Seiyaku Transdermal Drug Delivery System Product
Table 81. Teikoku Seiyaku Revenue in Transdermal Drug Delivery System Business (2020-2025) & (US$ Million)
Table 82. Teikoku Seiyaku Recent Development
Table 83. Bayer Company Details
Table 84. Bayer Business Overview
Table 85. Bayer Transdermal Drug Delivery System Product
Table 86. Bayer Revenue in Transdermal Drug Delivery System Business (2020-2025) & (US$ Million)
Table 87. Bayer Recent Development
Table 88. Lingrui Company Details
Table 89. Lingrui Business Overview
Table 90. Lingrui Transdermal Drug Delivery System Product
Table 91. Lingrui Revenue in Transdermal Drug Delivery System Business (2020-2025) & (US$ Million)
Table 92. Lingrui Recent Development
Table 93. Sanofi Company Details
Table 94. Sanofi Business Overview
Table 95. Sanofi Transdermal Drug Delivery System Product
Table 96. Sanofi Revenue in Transdermal Drug Delivery System Business (2020-2025) & (US$ Million)
Table 97. Sanofi Recent Development
Table 98. Qizheng Company Details
Table 99. Qizheng Business Overview
Table 100. Qizheng Transdermal Drug Delivery System Product
Table 101. Qizheng Revenue in Transdermal Drug Delivery System Business (2020-2025) & (US$ Million)
Table 102. Qizheng Recent Development
Table 103. Endo Company Details
Table 104. Endo Business Overview
Table 105. Endo Transdermal Drug Delivery System Product
Table 106. Endo Revenue in Transdermal Drug Delivery System Business (2020-2025) & (US$ Million)
Table 107. Endo Recent Development
Table 108. Huarun 999 Company Details
Table 109. Huarun 999 Business Overview
Table 110. Huarun 999 Transdermal Drug Delivery System Product
Table 111. Huarun 999 Revenue in Transdermal Drug Delivery System Business (2020-2025) & (US$ Million)
Table 112. Huarun 999 Recent Development
Table 113. Haw Par Company Details
Table 114. Haw Par Business Overview
Table 115. Haw Par Transdermal Drug Delivery System Product
Table 116. Haw Par Revenue in Transdermal Drug Delivery System Business (2020-2025) & (US$ Million)
Table 117. Haw Par Recent Development
Table 118. Nichiban Company Details
Table 119. Nichiban Business Overview
Table 120. Nichiban Transdermal Drug Delivery System Product
Table 121. Nichiban Revenue in Transdermal Drug Delivery System Business (2020-2025) & (US$ Million)
Table 122. Nichiban Recent Development
Table 123. Mentholatum Company Details
Table 124. Mentholatum Business Overview
Table 125. Mentholatum Transdermal Drug Delivery System Product
Table 126. Mentholatum Revenue in Transdermal Drug Delivery System Business (2020-2025) & (US$ Million)
Table 127. Mentholatum Recent Development
Table 128. Laboratoires Genevrier Company Details
Table 129. Laboratoires Genevrier Business Overview
Table 130. Laboratoires Genevrier Transdermal Drug Delivery System Product
Table 131. Laboratoires Genevrier Revenue in Transdermal Drug Delivery System Business (2020-2025) & (US$ Million)
Table 132. Laboratoires Genevrier Recent Development
Table 133. Transdermal Drug Delivery System Market Trends
Table 134. Transdermal Drug Delivery System Market Drivers
Table 135. Transdermal Drug Delivery System Market Challenges
Table 136. Transdermal Drug Delivery System Market Restraints
Table 137. Research Programs/Design for This Report
Table 138. Key Data Information from Secondary Sources
Table 139. Key Data Information from Primary Sources
List of Figures
Figure 1. Transdermal Drug Delivery System Product Picture
Figure 2. Global Transdermal Drug Delivery System Market Share by Type: 2024 VS 2031
Figure 3. Fentanyl Features
Figure 4. Nitroglycerin Features
Figure 5. Estradiol Features
Figure 6. Nicotine Features
Figure 7. Other Features
Figure 8. Global Transdermal Drug Delivery System Market Share by Application: 2024 VS 2031
Figure 9. OTC
Figure 10. Rx
Figure 11. Transdermal Drug Delivery System Report Years Considered
Figure 12. Global Transdermal Drug Delivery System Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 13. Global Transdermal Drug Delivery System Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 14. Global Transdermal Drug Delivery System Revenue Market Share by Region: 2020 VS 2024
Figure 15. North America Transdermal Drug Delivery System Revenue (US$ Million) Growth Rate (2020-2031)
Figure 16. Europe Transdermal Drug Delivery System Revenue (US$ Million) Growth Rate (2020-2031)
Figure 17. China Transdermal Drug Delivery System Revenue (US$ Million) Growth Rate (2020-2031)
Figure 18. Japan Transdermal Drug Delivery System Revenue (US$ Million) Growth Rate (2020-2031)
Figure 19. Global Transdermal Drug Delivery System Market Share by Players in 2024
Figure 20. Global Top Transdermal Drug Delivery System Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Transdermal Drug Delivery System as of 2024)
Figure 21. The Top 10 and 5 Players Market Share by Transdermal Drug Delivery System Revenue in 2024
Figure 22. North America Transdermal Drug Delivery System Market Share by Type (2020-2025)
Figure 23. North America Transdermal Drug Delivery System Market Share by Application (2020-2025)
Figure 24. Europe Transdermal Drug Delivery System Market Share by Type (2020-2025)
Figure 25. Europe Transdermal Drug Delivery System Market Share by Application (2020-2025)
Figure 26. China Transdermal Drug Delivery System Market Share by Type (2020-2025)
Figure 27. China Transdermal Drug Delivery System Market Share by Application (2020-2025)
Figure 28. Japan Transdermal Drug Delivery System Market Share by Type (2020-2025)
Figure 29. Japan Transdermal Drug Delivery System Market Share by Application (2020-2025)
Figure 30. Hisamitsu Revenue Growth Rate in Transdermal Drug Delivery System Business (2020-2025)
Figure 31. Mylan Revenue Growth Rate in Transdermal Drug Delivery System Business (2020-2025)
Figure 32. GSK Revenue Growth Rate in Transdermal Drug Delivery System Business (2020-2025)
Figure 33. Novartis Revenue Growth Rate in Transdermal Drug Delivery System Business (2020-2025)
Figure 34. Teve (Actavis) Revenue Growth Rate in Transdermal Drug Delivery System Business (2020-2025)
Figure 35. Johnson & Johnson Revenue Growth Rate in Transdermal Drug Delivery System Business (2020-2025)
Figure 36. Lohmann Revenue Growth Rate in Transdermal Drug Delivery System Business (2020-2025)
Figure 37. Teikoku Seiyaku Revenue Growth Rate in Transdermal Drug Delivery System Business (2020-2025)
Figure 38. Bayer Revenue Growth Rate in Transdermal Drug Delivery System Business (2020-2025)
Figure 39. Lingrui Revenue Growth Rate in Transdermal Drug Delivery System Business (2020-2025)
Figure 40. Sanofi Revenue Growth Rate in Transdermal Drug Delivery System Business (2020-2025)
Figure 41. Qizheng Revenue Growth Rate in Transdermal Drug Delivery System Business (2020-2025)
Figure 42. Endo Revenue Growth Rate in Transdermal Drug Delivery System Business (2020-2025)
Figure 43. Huarun 999 Revenue Growth Rate in Transdermal Drug Delivery System Business (2020-2025)
Figure 44. Haw Par Revenue Growth Rate in Transdermal Drug Delivery System Business (2020-2025)
Figure 45. Nichiban Revenue Growth Rate in Transdermal Drug Delivery System Business (2020-2025)
Figure 46. Mentholatum Revenue Growth Rate in Transdermal Drug Delivery System Business (2020-2025)
Figure 47. Laboratoires Genevrier Revenue Growth Rate in Transdermal Drug Delivery System Business (2020-2025)
Figure 48. Bottom-up and Top-down Approaches for This Report
Figure 49. Data Triangulation
Figure 50. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Oral Antianginal Drugs Market Outlook, In‑Depth Analysis & Forecast to 2031
Oct 21, 25
Global Polyester BCF Yarns Market Outlook, In‑Depth Analysis & Forecast to 2031
Oct 21, 25
Global Glass Mat Reinforced Thermoplastics (GMT) for Automotive Market Outlook, In‑Depth Analysis & Forecast to 2031
Oct 21, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232